Pre Transplant Rapamycin Treatment in Islet Transplantation Alone

PHASE3CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

December 31, 2005

Study Completion Date

September 30, 2009

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

rapamycin

Pre-transplant rapamycin is administered for at least four weeks prior to the first islet infusion at the dose of 0.1 mg/kg (target trough levels: 8-10 ng/mL).

Trial Locations (1)

20131

Transplant Unit, IRCCS San Raffaele, Milan

Sponsors
All Listed Sponsors
collaborator

Ministry of Education, Universities and Research, Italy

OTHER

collaborator

Juvenile Diabetes Research Foundation

OTHER

collaborator

Telethon-JDRF Center for Beta cell replacement: clinical core.

UNKNOWN

lead

IRCCS San Raffaele

OTHER